Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma

Summary

To investigate the ability of divalproex sodium, a histone deacetylase inhibitor, to improve the digital manifestations of scleroderma including digital edema, calcinosis cutis, digital ulcers, and joint contractures.

Timeline

Start

2014-06

Primary completion

2014-08

Completion

2014-08

Drugs

Indications